AstraZeneca's Anifrolumab Shows Benefit In Skin, Joint Diseases In Systemic Lupus Erythematosus PatientsBenzinga • 06/02/21
Proteros Enters Into Oncology Collaboration and License Agreement With AstraZenecaBusiness Wire • 06/02/21
COVID Vaccine Update: Where J&J, AstraZeneca, Novavax, and Sinovac Stand NowThe Motley Fool • 05/28/21
German scientists claim to know why AstraZeneca, Johnson & Johnson COVID-19 vaccines cause blood clotsProactive Investors • 05/27/21
AstraZeneca prices £691mln bond offering linked to Alexion Pharmaceuticals, Inc. acquisitionProactive Investors • 05/27/21
AstraZeneca's $39 billion takeover of U.S.-based Alexion Pharmaceuticals examined by U.K. regulatorMarket Watch • 05/25/21
AstraZeneca £27.5bn acquisition of Alexion under investigation by competition watchdogProactive Investors • 05/25/21
Coronavirus vaccines: UK hits 60mln doses milestone as new study proves AstraZeneca, Pfizer/BioNTech jabs work against Indian variantProactive Investors • 05/24/21
Japan Approves AstraZeneca's COVID Vaccine, But Puts Use on Hold Amid Blood Clot ConcernBenzinga • 05/21/21
AstraZeneca and Moderna receive approval for COVID-19 vaccines in JapanProactive Investors • 05/21/21
AstraZeneca ASCO 2021 Data Support Ambition to Revolutionize Cancer Outcomes by Treating Earlier and Transforming the Patient ExperienceBusiness Wire • 05/19/21